UNSPSC 51332900: Antipsychotic ergot alkaloids

Antipsychotic drugs made from alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists.

UNSPSC 51332900 Antipsychotic ergot alkaloids is a Class code that does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities — a Seminole County naloxone and drug deactivation systems procurement, a Texas HHS direct-to-manufacturer prescription program RFI, and a Minnesota cooperative purchasing alliance RFP for generic multi-source pharmaceuticals and OTC products — involve naloxone distribution, pharmacy benefit program design, and broad-based generic pharmaceutical supply respectively, none of which fall within the scope of antipsychotic ergot alkaloid medications. The source shows no actual state or local solicitations for antipsychotic ergot alkaloids themselves, suggesting either a significant tagging misalignment in the underlying procurement database or minimal recent demand for this specific pharmaceutical class among state and local buyers.

The code shows little relevant recent activity at the state and local level. Procurement professionals evaluating this UNSPSC code should not assume the recent opportunities reflect the intended scope; the tagging appears to conflate unrelated pharmaceutical and pharmacy supply procurements. Without documented demand for antipsychotic ergot alkaloids specifically, the code does not present a clear basis for business development planning. If your firm supplies antipsychotic ergot alkaloids to state and local health systems or pharmacy programs, direct market outreach to state Medicaid agencies, county health departments, and state psychiatric facilities would likely yield more actionable intelligence than tracking this code's current activity.